Scientists watch rare eye disease progress to prepare for future treatments
NCT ID NCT01736293
First seen Nov 01, 2025 · Last updated Jun 09, 2026 · Updated 33 times
Summary
This study follows 68 people with ABCA4 gene mutations (linked to Stargardt disease and other retinal degenerations) for up to 10 years. Researchers collect blood and skin samples and perform detailed eye exams to track how the disease changes over time. No treatment is given; the goal is to build a group of well-studied participants ready for future clinical trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINAL DEGENERATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.